What You Should Know:
– ArteraAI, a pioneer in multi-modal artificial intelligence (MMAI) for cancer treatment personalization, announced today an additional $20M in funding.
– This latest round, backed by prominent investors like Prosperity7 Ventures, EDBI,…
Continue Reading
Background: Androgen deprivation therapy (ADT), a standard treatment for prostate cancer (PC), causes many physical side effects. In particular, it causes metabolic changes such as fasting glucose abnormalities or accumulation of body fat, and…
Continue Reading
NHS Cheshire and Merseyside’s Radiology Imaging Network (CAMRIN) has secured funding from the NHS Transformation Directorate’s AI Diagnostic Fund to accelerate the deployment of AI to help diagnose lung cancer patients quicker.Up to £1.2…
Continue Reading
Breast cancer diagnoses among women under 50 have steadily risen, particularly in recent years, driven by estrogen-receptor-positive tumors, according to a study by Washington University School of Medicine. The research, spanning 2000 to 2019,…
Continue Reading
The partnership between ACRO, ACR, ASTRO, and ASCO signifies a pivotal effort to address the critical challenges posed by Medicare payment cuts in radiation oncology. As leaders in the field, these organizations pool their…
Continue Reading
What You Should Know:
– 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to…
Continue Reading
What You Should Know: – PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. – The expansion doubles the platform’s reach,…
Continue Reading
What You Should Know:
Personalis, Inc., a leader in advanced genomics for cancer, and ClearNote Health, Inc., a pioneer in epigenomic technologies, today unveiled an alliance through which Personalis will expand its pharmaceutical service offerings by…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup, TenAces.TenAces will utilize AI, integrating biology and machine learning algorithms, to discover molecular…
Continue Reading
By Shania Kennedy
January 30, 2024 – Researchers from City of Hope and its precision medicine research organization, the Translational Genomics Research Institute (TGen), have developed a machine learning (ML) approach that could facilitate the early…
Continue Reading
